Skip to main content
. Author manuscript; available in PMC: 2016 Nov 22.
Published in final edited form as: J Thorac Oncol. 2013 May;8(5):658–661. doi: 10.1097/JTO.0b013e31828d08ae

TABLE 2.

Summary of Adverse Events (>10% in All Patients, Based on 54 pts)

Total

(N = 54)

All Grade Grade 3, 4, or 5


Event n (%) n (%)
Abnormal electrolytes 25 46.3 3 5.6
Constitutional symptoms 24 44.4 3 5.6
Diarrhea 23 42.6 0 0
Elevated Alk phos 21 38.9 2 3.7
Abnormal liver enzymes 19 35.2 2 3.7
Hypertension 18 33.3 7 13
Rash 17 31.5 1 1.9
Anorexia 15 27.8 2 3.7
Hyperglycemia 15 27.8 0 0
Pain 15 27.8 1 1.9
Proteinuria 14 25.9 0 0
GI complaint 13 24.1 1 1.9
Infection 13 24.1 2 3.7
Renal insufficiency 12 22.2 0 0
Anemia 11 20.4 0 0
Pulmonary 11 20.4 3 5.6
Bleed 10 18.5 0 0
Hypoalbuminemia 7 13 1 1.9